News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
bemarituzumab stomach cancer

Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers

A new phase 3 trial of Bemarituzumab for patients with advanced gastric cancer is open for enrollment. Curious about clinical trials? Use our clinical trial navigator to find studies happening now.

Read Source
X